These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21982447)

  • 21. Rational design and optimization of downstream processes of virus particles for biopharmaceutical applications: current advances.
    Vicente T; Mota JP; Peixoto C; Alves PM; Carrondo MJ
    Biotechnol Adv; 2011; 29(6):869-78. PubMed ID: 21784144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New methods of protein purification. Expanded bed chromatography.
    Galaev IY
    Biochemistry (Mosc); 1998 Jun; 63(6):619-24. PubMed ID: 9668200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic plants as factories for biopharmaceuticals.
    Giddings G; Allison G; Brooks D; Carter A
    Nat Biotechnol; 2000 Nov; 18(11):1151-5. PubMed ID: 11062432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Step gradients in 3-zone simulated moving bed chromatography. Application to the purification of antibodies and bone morphogenetic protein-2.
    Kessler LC; Gueorguieva L; Rinas U; Seidel-Morgenstern A
    J Chromatogr A; 2007 Dec; 1176(1-2):69-78. PubMed ID: 18036537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatography-free recovery of biopharmaceuticals through aqueous two-phase processing.
    Azevedo AM; Rosa PA; Ferreira IF; Aires-Barros MR
    Trends Biotechnol; 2009 Apr; 27(4):240-7. PubMed ID: 19251328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biopharmaceuticals in China.
    Hu X; Ma Q; Zhang S
    Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [How to optimize biopharmaceutical treatment safety?].
    Prugnaud JL
    Bull Acad Natl Med; 2011 Mar; 195(3):679-95; discussion 695-8. PubMed ID: 22292313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel chemometric strategy based on the application of artificial neural networks to crossed mixture design for the improvement of recombinant protein production in continuous culture.
    Didier C; Forno G; Etcheverrigaray M; Kratje R; Goicoechea H
    Anal Chim Acta; 2009 Sep; 650(2):167-74. PubMed ID: 19720188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of standard and new generation hydrophobic interaction chromatography resins in the monoclonal antibody purification process.
    Chen J; Tetrault J; Ley A
    J Chromatogr A; 2008 Jan; 1177(2):272-81. PubMed ID: 17709111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designing new monoclonal antibody purification processes using mixed-mode chromatography sorbents.
    Toueille M; Uzel A; Depoisier JF; Gantier R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(13-14):836-43. PubMed ID: 21439915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distinctive separation attributes of mixed-mode resins and their application in monoclonal antibody downstream purification process.
    Chen J; Tetrault J; Zhang Y; Wasserman A; Conley G; Dileo M; Haimes E; Nixon AE; Ley A
    J Chromatogr A; 2010 Jan; 1217(2):216-24. PubMed ID: 19819462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparative liquid chromatography.
    Guiochon G
    J Chromatogr A; 2002 Aug; 965(1-2):129-61. PubMed ID: 12236522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive comparison of mixing, mass transfer, Chinese hamster ovary cell growth, and antibody production using Rushton turbine and marine impellers.
    Sandadi S; Pedersen H; Bowers JS; Rendeiro D
    Bioprocess Biosyst Eng; 2011 Sep; 34(7):819-32. PubMed ID: 21505815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid-state fermentation for Trichokonins production from Trichoderma koningii SMF2 and preparative purification of Trichokonin VI by a simple protocol.
    Song XY; Xie ST; Chen XL; Sun CY; Shi M; Zhang YZ
    J Biotechnol; 2007 Aug; 131(2):209-15. PubMed ID: 17669535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biopharmaceuticals from microorganisms: from production to purification.
    Jozala AF; Geraldes DC; Tundisi LL; Feitosa VA; Breyer CA; Cardoso SL; Mazzola PG; Oliveira-Nascimento L; Rangel-Yagui CO; Magalhães PO; Oliveira MA; Pessoa A
    Braz J Microbiol; 2016 Dec; 47 Suppl 1(Suppl 1):51-63. PubMed ID: 27838289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simulated moving bed chromatography for the separation of enantiomers.
    Rajendran A; Paredes G; Mazzotti M
    J Chromatogr A; 2009 Jan; 1216(4):709-38. PubMed ID: 19004446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioreactor scale-up and oxygen transfer rate in microbial processes: an overview.
    Garcia-Ochoa F; Gomez E
    Biotechnol Adv; 2009; 27(2):153-76. PubMed ID: 19041387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous counter-current chromatography for capture and polishing steps in biopharmaceutical production.
    Steinebach F; Müller-Späth T; Morbidelli M
    Biotechnol J; 2016 Sep; 11(9):1126-41. PubMed ID: 27376629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purification.
    Yigzaw Y; Piper R; Tran M; Shukla AA
    Biotechnol Prog; 2006; 22(1):288-96. PubMed ID: 16454522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and optimization of an adenovirus production process.
    Kamen A; Henry O
    J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.